Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne’s muscular dystrophy. The US FDA granted Ryan this trial under compassionate use. Ryan first began treatments at the Stem Cell Institute in Panama before being able to receive treatments in his hometown of Wichita, Kansas.
Duchenne’s Patient Ryan Benton Discusses His Experience with Stem Cell Therapy
Reviewed By:
Marcella Madera, M.D.
International Medical Director
With 20 years of experience and trained at the world's top institutions, Dr. Madera founded the world’s first integrative, holistic, and regenerative neurosurgical practice in 2017 and has partnered with Stem Cell Institute to further advance patient healing.